GO:0048631 regulation of skeletal muscle tissue growth: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048631 (regulation of skeletal muscle tissue growth) is a biological process that modulates the frequency, rate, or extent of skeletal muscle growth.
• Myostatin (MSTN) is a key negative regulator of skeletal muscle mass; its loss leads to dramatic muscle hypertrophy in mice.
• IGF-I signaling promotes muscle growth by stimulating protein synthesis and myoblast differentiation.
• Satellite cells are the primary stem cell population responsible for postnatal muscle growth and regeneration.
• MicroRNAs and pannexins fine-tune myoblast proliferation and differentiation, impacting muscle development.
• Dysregulation of muscle growth regulation contributes to cancer cachexia, sarcopenia, and muscular dystrophies.
Description
Skeletal muscle is a highly plastic tissue that adapts its mass in response to mechanical load, nutrients, and hormonal signals. The biological process that governs these changes is formally known as regulation of skeletal muscle tissue growth (GO:0048631). This term encompasses any process that modulates the frequency, rate, or extent of skeletal muscle growth. Understanding this process is fundamental to developmental biology, regenerative medicine, and the treatment of muscle-wasting conditions. Key regulatory mechanisms include the balance between protein synthesis and degradation, the activity of muscle stem cells (satellite cells), and the influence of local and systemic factors such as myostatin and insulin-like growth factor I (IGF-I). Research into GO:0048631 has revealed a complex interplay of signaling pathways, transcription factors, and non-coding RNAs. For instance, myostatin, a member of the TGF-beta superfamily, acts as a potent negative regulator of muscle mass; its genetic ablation in mice results in a dramatic increase in muscle fiber number and size. Conversely, IGF-I promotes muscle growth by activating anabolic pathways and enhancing myoblast differentiation. Satellite cells, which reside in a niche between the basal lamina and the sarcolemma, are essential for postnatal muscle growth and repair, and their self-renewal is tightly regulated. Dysregulation of skeletal muscle growth regulation is a hallmark of several pathological conditions, including cancer cachexia, sarcopenia, and muscular dystrophies. Therefore, elucidating the molecular players and mechanisms of GO:0048631 is not only of basic scientific interest but also holds promise for developing therapeutic interventions. This article provides a comprehensive overview of the definition, mechanisms, key genes, and research methodologies associated with this critical biological process.
regulation of skeletal muscle tissue growth At A Glance
| GO ID | GO:0048631 |
|---|---|
| GO term | regulation of skeletal muscle tissue growth |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate, or extent of skeletal muscle growth |
| Key regulators | Myostatin (MSTN), IGF-I, satellite cells, microRNAs, pannexins |
| Associated diseases | Cancer cachexia, sarcopenia, muscular dystrophies |
| Research methods | CRISPR knockout, RNA-seq, proteomics, imaging |
What Is GO:0048631?
According to the Gene Ontology, regulation of skeletal muscle tissue growth (GO:0048631) is defined as any process that modulates the frequency, rate, or extent of skeletal muscle growth. In other words, it includes all molecular and cellular events that control how much and how fast skeletal muscle tissue increases in size, whether during development, in response to exercise, or in pathological conditions. This regulation can occur at multiple levels, from growth factor signaling to gene expression and protein turnover.
Why Is regulation of skeletal muscle tissue growth Important in Cell Biology?
Regulation of skeletal muscle tissue growth is critical for maintaining muscle mass and function throughout life. Its dysregulation contributes to a wide range of clinical conditions, from age-related sarcopenia to cancer cachexia, a devastating syndrome characterized by progressive muscle wasting. Understanding the molecular mechanisms that control muscle growth can inform the development of therapies to prevent or reverse muscle loss. Moreover, skeletal muscle plays a central role in whole-body metabolism, and its growth regulation impacts glucose homeostasis and energy expenditure. Thus, research into GO:0048631 has broad implications for public health and disease management.
• Maintains muscle mass and strength for mobility and metabolic health.
• Dysregulation leads to cancer cachexia, a major cause of morbidity in cancer patients.
• Age-related muscle loss (sarcopenia) is linked to impaired growth regulation.
• Muscular dystrophies involve defective muscle growth and regeneration.
• Satellite cell dysfunction impairs muscle repair and growth.
• Myostatin inhibition is a therapeutic strategy for muscle-wasting diseases.
• IGF-I signaling is essential for muscle hypertrophy and repair.
• MicroRNAs fine-tune muscle development and are potential therapeutic targets.
• Vitamin D influences muscle growth and function, with implications for deficiency.
• Pannexins regulate myoblast differentiation and proliferation.
What Happens During regulation of skeletal muscle tissue growth?
Satellite Cell Activation and Proliferation
In simple terms: Muscle stem cells wake up and multiply to provide new cells for growth.
Satellite cells are the primary stem cells in skeletal muscle, located between the basal lamina and the sarcolemma. Upon growth stimuli or injury, they activate, proliferate, and either differentiate into myoblasts or self-renew to maintain the stem cell pool. This process is essential for postnatal muscle growth and regeneration. Key signaling pathways include Notch and Wnt, which regulate satellite cell quiescence and activation.
Myoblast Differentiation and Fusion
In simple terms: Muscle precursor cells merge to form larger muscle fibers.
Proliferating myoblasts exit the cell cycle and differentiate into myocytes, which then fuse with existing muscle fibers or with each other to form multinucleated myotubes. This process is driven by myogenic regulatory factors such as MyoD and myogenin. Pannexins, a family of membrane channels, have been shown to regulate myoblast differentiation and proliferation. MicroRNAs also play critical roles in modulating these steps.
Protein Synthesis and Degradation Balance
In simple terms: The cell builds new muscle proteins while breaking down old ones; growth occurs when building outpaces breakdown.
Muscle growth requires a net positive balance between protein synthesis and degradation. IGF-I signaling activates the PI3K/Akt/mTOR pathway, promoting protein synthesis and inhibiting proteolysis. Conversely, myostatin negatively regulates muscle growth by inhibiting Akt and activating FoxO transcription factors, leading to increased protein degradation. The ubiquitin-proteasome system and autophagy are major degradation pathways involved in muscle atrophy.
Hormonal and Nutritional Regulation
In simple terms: Hormones and nutrients tell muscles whether to grow or shrink.
Systemic factors such as insulin, IGF-I, testosterone, and vitamin D influence muscle growth. Vitamin D, for example, modulates muscle cell proliferation and differentiation through the vitamin D receptor. Nutritional status, particularly amino acid availability, also regulates mTOR signaling and protein synthesis. Cancer cachexia is driven by inflammatory cytokines that promote muscle wasting.
Mechanical Load and Exercise
In simple terms: Physical activity triggers signals that make muscles bigger and stronger.
Mechanical loading during exercise activates mechanosensors in muscle fibers, leading to increased IGF-I expression and mTOR signaling. This results in hypertrophy, characterized by increased cross-sectional area of muscle fibers. Satellite cells are also activated by exercise and contribute to muscle growth by donating nuclei to existing fibers.
Key Genes Involved in GO:0048631 regulation of skeletal muscle tissue growth
The following genes and proteins are central to the regulation of skeletal muscle tissue growth, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MSTN | Negative regulator of muscle mass; inhibits myoblast proliferation and differentiation | Knockout leads to muscle hypertrophy; target for muscle-wasting therapies |
| IGF1 | Promotes muscle growth via PI3K/Akt/mTOR; enhances protein synthesis | Overexpression induces hypertrophy; mediates exercise-induced growth |
| PAX7 | Satellite cell marker; required for satellite cell specification and maintenance | Knockout impairs muscle regeneration; key for stem cell biology |
| MYOD1 | Myogenic regulatory factor; drives myoblast differentiation | Knockout shows impaired myogenesis; used to study differentiation |
| MYOG | Myogenin; essential for terminal differentiation and myotube formation | Knockout leads to severe muscle defects; marker of differentiation |
| MEF2C | Transcription factor; cooperates with myogenic factors to activate muscle genes | Knockout affects muscle development; integrates signaling |
| FOXO1 | Transcription factor; promotes protein degradation and atrophy | Inhibition prevents muscle wasting; downstream of myostatin |
| AKT1 | Kinase; promotes protein synthesis and inhibits degradation | Overexpression induces hypertrophy; central to IGF-I signaling |
| MTOR | Kinase; master regulator of protein synthesis | Inhibition blocks hypertrophy; target of rapamycin |
| MIR1 | MicroRNA; regulates myoblast differentiation and proliferation | Dysregulation affects muscle development; potential therapeutic |
| MIR133 | MicroRNA; promotes myoblast proliferation | Knockout affects muscle growth; biomarker |
| PANX1 | Pannexin channel; regulates myoblast differentiation | Knockdown alters differentiation; role in purinergic signaling |
| PANX3 | Pannexin channel; involved in myoblast proliferation | Overexpression affects cell cycle; potential target |
| VDR | Vitamin D receptor; mediates vitamin D effects on muscle | Polymorphisms linked to muscle strength; knockout shows impaired growth |
| MYF5 | Myogenic factor; specifies myoblast fate | Knockout affects muscle formation; early marker |
| MYF6 | Myogenic factor; involved in differentiation | Mutations linked to muscle disorders; research model |
| TCF4 | Transcription factor; regulates satellite cell quiescence | Knockout leads to premature activation; stem cell niche |
| NOTCH1 | Receptor; maintains satellite cell quiescence | Inhibition causes differentiation; key signaling |
How Is regulation of skeletal muscle tissue growth Regulated?
The regulation of skeletal muscle tissue growth is orchestrated by a network of signaling pathways. The IGF-I/PI3K/Akt/mTOR axis is a major anabolic pathway that promotes protein synthesis and muscle hypertrophy. Myostatin, a TGF-beta family member, acts as a negative regulator by inhibiting Akt and activating FoxO-mediated protein degradation. Satellite cell activity is controlled by Notch signaling, which maintains quiescence, and by Wnt signaling, which promotes activation and differentiation. MicroRNAs such as miR-1 and miR-133 fine-tune the expression of key myogenic factors. Additionally, pannexins modulate myoblast differentiation through ATP release and purinergic signaling. Vitamin D, via the vitamin D receptor, also influences muscle cell proliferation and differentiation. These pathways are integrated to ensure appropriate muscle growth in response to developmental cues, exercise, and injury.
regulation of skeletal muscle tissue growth and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MSTN | Muscle hypertrophy; cachexia | MSTN knockout mouse; CRISPR KO in C2C12 cells |
| IGF1 | Muscle atrophy; sarcopenia | IGF1 overexpression mouse; CRISPR knock-in of IGF1 variant |
| PAX7 | Satellite cell dysfunction; dystrophy | PAX7 knockout mouse; CRISPR KO in primary myoblasts |
| VDR | Vitamin D deficiency myopathy | VDR knockout mouse; CRISPR KO in C2C12 |
| FOXO1 | Muscle wasting; cachexia | FOXO1 knockout mouse; CRISPR KO in myotubes |
Cancer Cachexia
Cancer cachexia is a multifactorial syndrome characterized by severe muscle wasting, which cannot be fully reversed by nutritional support. It is driven by systemic inflammation and tumor-derived factors that promote protein degradation and inhibit protein synthesis, leading to a negative net balance in muscle growth regulation. Myostatin and IGF-I signaling are often dysregulated in cachexia, making them potential therapeutic targets.
Sarcopenia
Sarcopenia is the age-related loss of muscle mass and strength. It involves a decline in satellite cell function, reduced anabolic signaling (e.g., IGF-I), and increased catabolic signaling. Vitamin D deficiency has been implicated in sarcopenia, as the vitamin D receptor regulates muscle cell proliferation and differentiation. Understanding the regulation of muscle growth is crucial for developing interventions to prevent or slow sarcopenia.
Muscular Dystrophies
Muscular dystrophies are genetic disorders characterized by progressive muscle weakness and degeneration. In Duchenne muscular dystrophy, the absence of dystrophin leads to repeated cycles of muscle damage and regeneration, eventually exhausting satellite cells and impairing muscle growth. Therapies aimed at enhancing muscle growth and regeneration, such as myostatin inhibition, are being explored.
Myostatin-Related Muscle Hypertrophy
Mutations in the MSTN gene cause a rare condition known as myostatin-related muscle hypertrophy, characterized by increased muscle mass and strength. This condition highlights the critical role of myostatin as a negative regulator of muscle growth. Studying such mutations provides insights into the mechanisms that limit muscle size and may inform therapies for muscle-wasting diseases.
From regulation of skeletal muscle tissue growth-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate muscle growth? | CRISPR knockout in C2C12 myoblasts or mouse models |
| What is the effect of a point mutation in gene X? | CRISPR point mutation knock-in in C2C12 or primary myoblasts |
| How does overexpression of gene X affect muscle mass? | CRISPR-mediated overexpression (e.g., CRISPRa) or transgenic mouse |
| Where is protein X localized during muscle growth? | Tagged knock-in (e.g., GFP) in C2C12 or mouse |
| What is the role of gene X in satellite cell function? | Conditional knockout in Pax7-CreERT2 mice |
| Can gene X be targeted for muscle-wasting therapy? | CRISPR knockout in disease models (e.g., cancer cachexia mouse) |
How to Study the regulation of skeletal muscle tissue growth Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function of a gene | Identify essential regulators of muscle growth |
| RNA-seq | Transcriptome-wide gene expression | Discover differentially expressed genes during growth |
| Proteomics | Protein abundance and modifications | Quantify changes in signaling pathways |
| Immunofluorescence | Protein localization and cell morphology | Assess satellite cell activation and myofiber size |
| EdU incorporation | DNA synthesis (proliferation) | Measure myoblast proliferation |
| Fusion index | Myotube formation | Evaluate myoblast differentiation |
| Puromycin incorporation | Protein synthesis rate | Assess anabolic signaling |
| CRISPR activation (CRISPRa) | Gene overexpression | Study gain-of-function effects on muscle growth |
CRISPR-Based Genetic Screens
Pooled CRISPR knockout or activation screens can identify novel regulators of skeletal muscle growth. For example, a genome-wide knockout screen in C2C12 myoblasts can reveal genes that affect proliferation or differentiation. Hits can be validated individually using targeted CRISPR models.
Transcriptomic and Proteomic Profiling
RNA sequencing (RNA-seq) and mass spectrometry-based proteomics allow comprehensive analysis of gene expression and protein abundance during muscle growth. These methods can identify differentially expressed genes and pathways, such as those involving myostatin or IGF-I. Single-cell RNA-seq can resolve heterogeneity in satellite cell populations.
Imaging and Histology
Immunofluorescence and confocal microscopy can visualize satellite cell activation, myoblast fusion, and myofiber size. Staining for markers like Pax7, MyoD, and myosin heavy chain provides spatial and quantitative information about muscle growth. Time-lapse imaging can track dynamic processes.
Functional Assays
In vitro assays such as EdU incorporation for proliferation, myotube fusion index for differentiation, and protein synthesis/degradation assays (e.g., puromycin incorporation, proteasome activity) are used to measure muscle growth regulation. These are often combined with genetic perturbations.
How CRISPR Can Be Used to Study GO:0048631 regulation of skeletal muscle tissue growth
Knockout
CRISPR knockout is used to completely ablate a gene of interest to study its role in muscle growth. For example, knocking out MSTN in C2C12 cells or mice leads to increased myoblast proliferation and muscle hypertrophy, confirming its negative regulatory role. Knockout of PAX7 impairs satellite cell function and muscle regeneration.
Point Mutation
CRISPR point mutation (e.g., via base editing or HDR) allows the introduction of specific disease-associated mutations. For instance, a point mutation in the VDR gene can mimic vitamin D resistance, helping to elucidate its role in muscle growth. This approach is valuable for studying structure-function relationships.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags enables visualization and tracking of endogenous proteins. Tagging MYOD1 with GFP allows real-time monitoring of myoblast differentiation. Knock-in of human disease alleles into mouse models can recapitulate human phenotypes.
Overexpression
CRISPR activation (CRISPRa) or transgenic approaches can overexpress genes to study gain-of-function effects. Overexpression of IGF1 in muscle leads to hypertrophy, demonstrating its anabolic role. Overexpression of microRNAs such as miR-1 can inhibit differentiation, affecting muscle growth.
How EDITGENE Supports regulation of skeletal muscle tissue growth Research
Researchers studying regulation of skeletal muscle tissue growth-related genes often need to determine whether a candidate gene is causally involved in muscle development, regeneration, or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for regulation of skeletal muscle tissue growth research.
Frequently Asked Questions About regulation of skeletal muscle tissue growth
What is GO:0048631?
GO:0048631 is the Gene Ontology term for regulation of skeletal muscle tissue growth, defined as any process that modulates the frequency, rate, or extent of skeletal muscle growth.
What genes are involved in regulation of skeletal muscle tissue growth?
Key genes include MSTN (myostatin), IGF1, PAX7, MYOD1, MYOG, and microRNAs such as miR-1 and miR-133.
How does myostatin regulate muscle growth?
Myostatin negatively regulates muscle growth by inhibiting myoblast proliferation and differentiation and promoting protein degradation.
What is the role of satellite cells in muscle growth?
Satellite cells are muscle stem cells that activate, proliferate, and differentiate to contribute to muscle growth and repair.
How does IGF-I promote muscle growth?
IGF-I activates the PI3K/Akt/mTOR pathway, enhancing protein synthesis and inhibiting degradation, leading to muscle hypertrophy.
What diseases are associated with dysregulation of muscle growth?
Cancer cachexia, sarcopenia, and muscular dystrophies are associated with impaired regulation of muscle growth.
How can CRISPR be used to study muscle growth regulation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of genes involved in muscle growth.
What methods are used to study regulation of skeletal muscle tissue growth?
Common methods include RNA-seq, proteomics, immunofluorescence, and functional assays like EdU incorporation and fusion index.
What is the role of microRNAs in muscle growth?
MicroRNAs such as miR-1 and miR-133 fine-tune myoblast proliferation and differentiation, impacting muscle development.
How does vitamin D affect muscle growth?
Vitamin D, via the vitamin D receptor, regulates muscle cell proliferation and differentiation, and deficiency is linked to muscle weakness.
Conclusion
Regulation of skeletal muscle tissue growth (GO:0048631) is a fundamental biological process with profound implications for health and disease. The interplay between positive regulators like IGF-I and negative regulators like myostatin, along with satellite cell dynamics and microRNA networks, determines muscle mass. Dysregulation contributes to cachexia, sarcopenia, and dystrophies, making this process a prime therapeutic target. Advances in CRISPR technology and omics approaches are accelerating the discovery of new regulatory mechanisms and potential interventions. EDITGENE's suite of services supports researchers in unraveling these complexities and translating findings into clinical applications.
References
- 1. Fearon K et al.. 2011. Definition and classification of cancer cachexia: an international consensus.. Lancet Oncol 12(5):489-95 PMID: 21296615
- 2. Yin H et al.. 2013. Satellite cells and the muscle stem cell niche.. Physiol Rev 93(1):23-67 PMID: 23303905
- 3. McPherron AC et al.. 1997. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member.. Nature 387(6628):83-90 PMID: 9139826
- 4. Frost RA et al.. 2003. Regulation of insulin-like growth factor-I in skeletal muscle and muscle cells.. Minerva Endocrinol 28(1):53-73 PMID: 12621363
- 5. Giordani L et al.. 2018. Satellite Cell Self-Renewal.. Curr Top Dev Biol 126:177-203 PMID: 29304998
- 6. Langlois S et al.. 2017. Regulation of Skeletal Muscle Myoblast Differentiation and Proliferation by Pannexins.. Adv Exp Med Biol 925:57-73 PMID: 27518505
- 7. Wang J et al.. 2018. Effects of microRNAs on skeletal muscle development.. Gene 668:107-113 PMID: 29775754
- 8. Montenegro KR et al.. 2019. Mechanisms of vitamin D action in skeletal muscle.. Nutr Res Rev 32(2):192-204 PMID: 31203824
